Minimal residual disease (MRD) in follicular lymphoma in the era of immunotherapy with rituximabHIRT, Carsten; SCHÜLER, Frank; DOLKEN, Gottfried et al.Seminars in cancer biology. 2003, Vol 13, Num 3, pp 223-231, issn 1044-579X, 9 p.Article

Lacking immunocytological GD2 expression in neuroblastoma : Report of three casesSCHUMACHER-KUCKELKORN, Roswitha; HERO, Barbara; ERNESTUS, Karen et al.Pediatric blood & cancer. 2005, Vol 45, Num 2, pp 195-201, issn 1545-5009, 7 p.Article

Identification of complement C3f-desArg and its derivative for acute leukemia diagnosis and minimal residual disease assessmentTINGTING LIANG; NA WANG; ZHONGHUA DU et al.Proteomics (Weinheim. Print). 2010, Vol 10, Num 1, pp 90-98, issn 1615-9853, 9 p.Article

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemiaWAANDERS, E; VAN DER VELDEN, Vhj; VAN DONGEN, Jjm et al.Leukemia. 2011, Vol 25, Num 2, pp 254-258, issn 0887-6924, 5 p.Article

The importance of molecular monitoring in acute promyelocytic leukaemiaLO-COCO, Francesco; BRECCIA, Massimo; DIVERIO, Daniela et al.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 503-520, issn 1521-6926, 18 p.Article

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia : a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoringBOUBLIKOVA, L; KALINOVA, M; LAWLER, M et al.Leukemia. 2006, Vol 20, Num 2, pp 254-263, issn 0887-6924, 10 p.Article

Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemiaKRAMPERA, Mauro; VITALE, Antonella; NOBILE, Francesco et al.British journal of haematology. 2003, Vol 120, Num 1, pp 74-79, issn 0007-1048, 6 p.Article

The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastomaSTUTTERHEIM, J; ZAPPEIJ-KANNEGIETER, L; VERSTEEG, R et al.European journal of cancer (1990). 2011, Vol 47, Num 8, pp 1193-1202, issn 0959-8049, 10 p.Article

Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patientsTOUBAI, Tomomi; TANAKA, Junji; KAWAMURA, Tsugumichi et al.American journal of hematology. 2005, Vol 80, Num 3, pp 181-187, issn 0361-8609, 7 p.Article

TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapseVAN DER VELDEN, V. H. J; BRÜGGEMANN, M; KNEBA, M et al.Leukemia. 2004, Vol 18, Num 12, pp 1971-1980, issn 0887-6924, 10 p.Article

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsVAN DER VELDEN, V. H. J; HOCHHAUS, A; CAZZANIGA, G et al.Leukemia. 2003, Vol 17, Num 6, pp 1013-1034, issn 0887-6924, 22 p.Article